Information Library
Results for: Capital
In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions. Search our library today.
- Sort by:
- Recently Added
- Title
-
Intarcia and Quintiles Finalize Innovative Alliance
Press Release — December 13, 2011 – To speed development of a potential ground-breaking therapy for Type 2 diabetes – Intarcia Therapeutics, Inc., and Quintiles announced the signing of definitive agreements making Quintiles a financial and strategic partner for the global clinical development of Intarcia’s ITCA 650 (DUROS® continuous subcutaneous delivery of exenatide).
-
Quintiles Launches China CRO, Kun Tuo
Press Release — December 13, 2011 – Further deepening its commitment to China, Quintiles announced the launch of Kun Tuo, a local contract research organization (CRO) built to service the unique needs of the Chinese biopharmaceutical industry and multinational biopharma companies operating in China.
-
Strategic Alliances
White Paper — December 5, 2011
Strategic alliances with specialized external partners allow companies to increase agility and the efficiency of processes, variablize resources and raise the number of promising drug candidates in their pipeline. -
Understanding the Complexity of HTA Networks
Presentation — November 27, 2011
As stakeholders’ influence shifts, demonstrating value is imperative for the success of every pharmaceutical product. Learn more about Quintiles HTA Watch service. -
Quintiles Acquires VCG & Associates and VCG Bio
Press Release — October 19, 2011 – The acquisition of VCG & Associates and VCG BIO strengthens Quintiles’ comprehensive commercial services in sales and brand solutions, product solutions, product distribution and market access.
-
Partnering to Maximize Rewards in Pharmerging Markets
White Paper — September 15, 2011
In the past few years so-called “pharmerging” markets have been heralded as the hottest growth area for biopharmaceutical drugs. With large populations, growing disposable income and unmet medical needs, these markets have seen doubledigit growth rates in pharmaceutical spending. -
Quintiles, Kadrige Open E-Solutions Operation in the US
Press Release — August 2, 2011 – Quintiles and Kadrige, the market leader in e-detailing and multichannel sales solutions for the pharmaceutical and healthcare industries, today announced the opening of the first Kadrige office in the U.S.
-
Podcast: Key FSP stakeholders - roles, relationships and impacts
Hear from the Experts — May 16, 2011
Fred Cooley, Senior Director, Clinical Operations, North America Field Monitoring Group, describes key stakeholders in Functional Service Provider Relationships. -
Podcast: The Benefits and Drawbacks of Functional Service Provider Arrangements (FSPs)
Hear from the Experts — May 16, 2011
Ian Birks, Vice President, Integration, Resourcing, Metrics & Reporting, discusses the benefits and drawbacks of Functional Service Provider Arrangements (FSPs) -
Quintiles and Population Genetics Technologies Partner
Press Release — May 16, 2011 – Quintiles, and Population Genetics Technologies Ltd. (PGT), announced a commercial collaboration to bring genomic testing into mainstream drug development in order to produce safer, more effective medicines.
